115 related articles for article (PubMed ID: 8330994)
21. Response of glioblastoma cell lines to low dose rate irradiation.
Marin LA; Smith CE; Langston MY; Quashie D; Dillehay LE
Int J Radiat Oncol Biol Phys; 1991 Jul; 21(2):397-402. PubMed ID: 2061116
[TBL] [Abstract][Full Text] [Related]
22. Thermal radiosensitization by 41 degrees C hyperthermia during low dose-rate irradiation in human normal and tumour cell lines.
Raaphorst GP; Heller DP; Bussey A; Ng CE
Int J Hyperthermia; 1994; 10(2):263-70. PubMed ID: 8064184
[TBL] [Abstract][Full Text] [Related]
23. In vitro transformation by bromodeoxyuridine and X irradiation in C3H 10T1/2 cells.
Raaphorst GP; Azzam EI; Borsa J; Sargent MD
Radiat Res; 1985 Feb; 101(2):279-91. PubMed ID: 3975357
[TBL] [Abstract][Full Text] [Related]
24. Use of fluorescence in situ hybridization (FISH) to study chromosomal damage induced by radiation and bromodeoxyuridine in human colon cancer cells.
Wilt SR; Burgess AC; Normolle DP; Trent JM; Lawrence TS
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):861-6. PubMed ID: 7960988
[TBL] [Abstract][Full Text] [Related]
25. Hyperthermia and incorporation of halogenated pyrimidines: radiosensitization in cultured rodent and human tumor cells.
Van Bree C; Franken NA; Bakker PJ; Klomp-Tukker LJ; Barendsen GW; Kipp JB
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):489-96. PubMed ID: 9308955
[TBL] [Abstract][Full Text] [Related]
26. PALA enhancement of bromodeoxyuridine incorporation into DNA increases radiation cytotoxicity to human ovarian adenocarcinoma cells.
Yang JL; Fernandes DJ; Wheeler KT; Capizzi RL
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1073-9. PubMed ID: 8600090
[TBL] [Abstract][Full Text] [Related]
27. Low dose rate radiotherapy for transplantable gliosarcoma in the rat brain.
Kim JH; Alfieri AA; Rosenblum M; Bravo S; Kim SH
J Neurooncol; 1990 Aug; 9(1):9-15. PubMed ID: 2213119
[TBL] [Abstract][Full Text] [Related]
28. [Chemical modifiers in radiotherapy].
Nagashima T; Takakura K
Gan No Rinsho; 1989 Sep; 35(11):1369-71. PubMed ID: 2681875
[TBL] [Abstract][Full Text] [Related]
29. Misonidazole combined with hyperfractionation in the management of malignant glioma.
Fulton DS; Urtasun RC; Shin KH; Geggie PH; Thomas H; Muller PJ; Moody J; Tanasichuk H; Mielke B; Johnson E
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1709-12. PubMed ID: 6090367
[TBL] [Abstract][Full Text] [Related]
30. Iododeoxyuridine radiosensitization of human glioblastoma cells exposed to acute and chronic gamma irradiation: mechanistic implications and clinical relevance.
Schultz CJ; Gaffney DK; Lindstrom MJ; Kinsella TJ
Cancer J Sci Am; 1995; 1(2):151-61. PubMed ID: 9166468
[TBL] [Abstract][Full Text] [Related]
31. Boron neutron capture therapy for murine malignant gliomas.
Saris SC; Solares GR; Wazer DE; Cano G; Kerley SE; Joyce MA; Adelman LS; Harling OK; Madoc-Jones H; Zamenhof RG
Cancer Res; 1992 Sep; 52(17):4672-7. PubMed ID: 1511433
[TBL] [Abstract][Full Text] [Related]
32. Cell-cycle progression during continuous low dose rate irradiation of a human bladder carcinoma cell line.
Skladowski K; McMillan TJ; Peacock J; Titley J; Steel GG
Radiother Oncol; 1993 Sep; 28(3):219-27. PubMed ID: 8255999
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin and low dose rate irradiation in cisplatin resistant and sensitive human glioma cells.
Wilkins DE; Ng CE; Raaphorst GP
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):105-11. PubMed ID: 8823265
[TBL] [Abstract][Full Text] [Related]
34. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
Yuan X; Dillehay LE; Williams JR; Williams JA
Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
[TBL] [Abstract][Full Text] [Related]
35. Tumor radiosensitization by sustained intratumoral release of bromodeoxyuridine.
Doiron A; Yapp DT; Olivares M; Zhu JX; Lehnert S
Cancer Res; 1999 Aug; 59(15):3677-81. PubMed ID: 10446981
[TBL] [Abstract][Full Text] [Related]
36. Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors.
Phuphanich S; Levin EM; Levin VA
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1769-72. PubMed ID: 6480461
[TBL] [Abstract][Full Text] [Related]
37. Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).
Sano K; Hoshino T; Nagai M
J Neurosurg; 1968 Jun; 28(6):530-8. PubMed ID: 4233585
[No Abstract] [Full Text] [Related]
38. Radiosensitization by bromodeoxyuridine and hyperthermia: analysis of linear and quadratic parameters of radiation survival curves of two human tumor cell lines.
Franken NA; Van Bree C; Veltmaat MA; Rodermond HM; Haveman J; Barendsen GW
J Radiat Res; 2001 Jun; 42(2):179-90. PubMed ID: 11599884
[TBL] [Abstract][Full Text] [Related]
39. Differential modification of radiation damage in 5-bromo-2-deoxy-uridine sensitized human glioma cells and PHA-stimulated peripheral leukocytes by 2-deoxy-D-glucose.
Kalia VK; Devi NK
Indian J Exp Biol; 1994 Sep; 32(9):637-42. PubMed ID: 7814043
[TBL] [Abstract][Full Text] [Related]
40. The biological effectiveness of intermittent irradiation as a function of overall treatment time: development of correction factors for linac-based stereotactic radiotherapy.
Benedict SH; Lin PS; Zwicker RD; Huang DT; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):765-9. PubMed ID: 9128949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
